Voloridge Investment Management
PNT

Voloridge Investment Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Voloridge Investment Management’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-62,156
Closed -$415K – 1555
2023
Q3 		$415K Buy
62,156
+2,497
+4% +$20.8K ﹤0.01% 1234
2023
Q2 		$541K Buy
+59,659
New +$526K ﹤0.01% 1220

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Voloridge Investment Management's PNT Position: Q4 2023 in Review

Voloridge Investment Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 62,156 shares — an estimated $415K sold.

Voloridge Investment Management first reported a position in PNT in Q2 2023 and held it in 2 quarters. The position peaked at $541K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Voloridge Investment Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 62,156 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $415K.
  • Voloridge Investment Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Voloridge Investment Management's POINT Biopharma Global Inc. Common Stock position peaked at $541K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Voloridge Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.